Our paper on Semaphorin and Hippo signaling in tumor growth, angiogenesis, and mechanosensing has been officially accepted by Science Advances.
Dr. Zhipeng Meng is a co-corresponding author, and Dr. Ying Wang and Dr. Xiaomin Cai are co-authors of this study.
Our collaborator Dr. Rongze Lu’s R01 to NINDS has received a great score.
Great achievement for an ESI (12%). As the co-I of the grant, we are thrilled and look forward to working with Dr. Rongze Lu on the proposed experiments!
The Elsa U. Pardee Foundation has funded our breast cancer research!
A grant of $182,429.00 will support our research on identifying new therapies for Triple-Negative Breast Cancer.
Our First NIH Grant!!!
We have been funded by a 5-year NIGMS-MIRA (R35) grant. The major goals of this project are to understand the molecular mechanisms by which mechanical cues regulate tissue regeneration and fibrosis via a Non-Canonical Hippo pathway.
Dr. Zhipeng Meng has been funded by Stanley J. Glaser Foundation.
This award is to support a breast cancer project in Dr. Meng’s lab. The major goals of this project are to identify regulatory mechanisms and therapeutic potential of a novel Semaphorin-Hippo signaling in Triple Negative Breast Cancer.
Our first paper has been online now:
Several positions for graduate students and postdocs are available in our lab. Please email email@example.com for more information.
GET IN TOUCH